Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
COSCIENS Biopharma Inc
T.AEZS
Healthcare
Biotechnology
COSCIENS Biopharma Inc., formerly Aeterna Zentaris Inc., is a specialty biopharmaceutical company engaged in the development and commercialization of a diverse portfolio of pharmaceutical and diagnostic products, including those focused on areas of unmet medical need. Its lead product, macimorelin (Macrilen; Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone...
deficiency (AGHD). The Company is also engaged in the development of therapeutic assets and proprietary extraction technology, which is applied to the production of active ingredients from renewable plant resources used in cosmeceutical products (i.e., oat beta glucan and avenanthramides, which are found in skincare product brands like Aveeno and Burt’s Bees formulations) and being developed as potential nutraceuticals and/or pharmaceuticals.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:AEZS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 27, 2024 12:37pm
As we await the first avenanthramide trial results...
The Lancet Publishes Results from World's Largest Coronary CT Registry Showing New AI Technology Can Predict Cardiac Events Due to Coronary Inflammation At Least 10 Years in Advance
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 27, 2024 12:31pm
PGX-YBG/Fibrosis
In October Gilles said that PGX-YBG/Fibrosis only required a short toxicology study and that they were moving ahead with planning a human clinical trail regardless. While it wasn't a full
...more
Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million
posted Nov 21, 2024 9:00am by
Innocan Pharma Corp
-
|
"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more
(153)
•••
Hopeforthebest
X
View Profile
View Bullboard History
Comment by
Hopeforthebest
on Jun 27, 2024 12:16pm
RE:RE:I'm concerned .
Apostata, You are absolutely to correct to be worried, gagnon over the last 25 years has driven 3 companies in the ground and by combining these 3 failures under 1 new name will only result in more
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 27, 2024 9:42am
RE:RE:I'm concerned .
"Here's the difference: they had a plan for Rome." Why don't you think developing a pharma-grade avenanthramide pill and approving a Phase I/IIa clinical trial with Health
...more
(46)
•••
Apostata
X
View Profile
View Bullboard History
Comment by
Apostata
on Jun 27, 2024 9:20am
RE:I'm concerned .
This really sums up how a lot of us are feeling. Personally I feel like I'm caught in a scam in order to finance Gilles Gagnon's retirement. "And I do know that Rome wasn't built
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 27, 2024 7:59am
RE:Can we draw a line through the data?
You can also add that CZO previously said it was experimenting with avenanthramide and newer generation PGX carriers previously. The Angiogenesis Foundation is also experimenting with AEZS's oat
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 27, 2024 7:34am
Can we draw a line through the data?
PGX-YBG is found multi-fold more immune stimulative than competitors in human cell-lines. Gilles considers it so compelling he might want to go-it-alone in the immune booster market with 40 million
...more
(13)
•••
jrsloan60
X
View Profile
View Bullboard History
Post by
jrsloan60
on Jun 26, 2024 11:47am
I'm concerned .
I thought we were building a company on the stock market . That would be liquid. Have fear of buying any more shares because they're so in illiquid if that's a word. Since we've decided to
...more
(34)
•••
Tencents
X
View Profile
View Bullboard History
Comment by
Tencents
on Jun 25, 2024 1:39pm
RE:Merger closed, proposed name announced, AGM in 21 days...
I would expect the following to happen at the agm 1. approval of name 2. approval of merger 3.appointment of auditors@ 4. approval of board@ 5.approval of financial statements 2023@ operational
...more
(34)
•••
Tencents
X
View Profile
View Bullboard History
Comment by
Tencents
on Jun 25, 2024 1:37pm
RE:Merger closed, proposed name announced, AGM in 21 days...
I would expect the following to happen at the agm 1. approval of name 2. approval of merger 3.appointment of auditors 4. approval of board 5.approval of financial statements 2023
...more
(28)
•••
tigerpro
X
View Profile
View Bullboard History
Comment by
tigerpro
on Jun 25, 2024 1:02pm
RE:RE:Merger Concessions
Oat, replied just now. please check your message box again. Thanks.
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 25, 2024 8:43am
Merger closed, proposed name announced, AGM in 21 days...
What happens before and at the AGM before the vote? Nothing? 1) The last person last visit for the diagnostic clinical trial was 11 days ago with top-line results expected in Q3. Do we get the
...more
(28)
•••
tigerpro
X
View Profile
View Bullboard History
Comment by
tigerpro
on Jun 25, 2024 12:37am
RE:Merger Concessions
Oat, please check your message box.
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Jun 24, 2024 7:56pm
RE:Proposed name: COSCIENS Biopharma Inc.
They are looking to partner ALS and DC-PTH. If costs for those two programs are the responsibility of future partners as the costs of the diagnostic test clinical trial fall off that could change
...more
(109)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Jun 24, 2024 7:29pm
COSCIENS & word-of-mouth advertising
Perplexity Ai: To evaluate whether COSCIENS is ideal for word-of-mouth advertising, let's consider some key factors that make brand names effective for word-of-mouth marketing:Memorability
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Discover Options Trading Strategies to Minimize your Tax Burden